Proceedings of the Twenty-Fifth Symposium on Biotechnology for Fuels and Chemicals Held May 4-7, 2003, in Breckenridge, CO
-4 %

Proceedings of the Twenty-Fifth Symposium on Biotechnology for Fuels and Chemicals Held May 4-7, 2003, in Breckenridge, CO

 Taschenbuch
Besorgungstitel | Lieferzeit:3-5 Tage I

Unser bisheriger Preis:ORGPRICE: 338,50 €

Jetzt 324,45 €*

Alle Preise inkl. MwSt. | zzgl. Versand
ISBN-13:
9781588294807
Einband:
Taschenbuch
Erscheinungsdatum:
15.05.2004
Seiten:
1223
Autor:
Mark Finkelstein
Gewicht:
4 g
Format:
255x176x57 mm
Serie:
Applied Biochemistry and Biotechnology
Sprache:
Englisch
Beschreibung:

Springer Book Archives
1 Molecular Diagnostics in Neoplastic Hematopathology Daniel A. Arber

2 HER2 and Topoisomerase IIa in Breast Carcinoma
Kenneth J. Bloom

3 Study of Sentinel Lymph Nodes for Staging Malignant Neoplasms
Alice A. Roberts and Alistair J. Cochran

4 Prostate Cancer Markers: From Discovery to the Clinic
Judith A. Finlay, Stephen D. Mikolajczyk, Thomas M. Pribyl, R. Bruce Wallace, and Harry G. Rittenhouse

5 Diagnosis of Ataxia-Telangiectasia: ATM Mutations Associated with Cancer
Midori Mitui, Shareef A. Nahas, Helen H. Chun, and Richard A. Gatti

6 Microsatellite Alterations as Diagnostic and Prognostic Markers in Patients with Cancer
Bret Taback and Dave S. B. Hoon

7 Chromosomal and Molecular Cytogenetic Assays for Evaluation of Human Tumors
Peter C. Hu, Armand B. Glassman, and Vicki L. Hopwood

8 New Insights and Future Advances in Cancer Diagnostics: Limitations of Conventional Tumor Markers
Yasushi Kasahara and Yutaka Tsukada

9 MHC Tetramers: A Tool for Direct Ex Vivo Detection and Enumeration of Tumor Specific Cytotoxic T Cells
Kristine Kuus-Reichel, Jennie Chang, Ferdynand Kos, and Charles T. Nugent

10 Serum Tumor Marker Test Profile in Testicular Germ Cell Tumors
Frank J. Liu, Robert M. Nakamura, C. Howard Tseng, and Kevin S. Liu

11 A Marker for Early Diagnosis of Lung Cancer: The Heterogeneous Nuclear Ribonucleoprotein A2/B1 (hnRNP A2/B1)
Jordi Tauler, Alfredo Martinez, and James L. Mulshine

12 New Applications of Flow Cytometry in Cancer Diagnosis and Therapy
Sophie Song and Faramarz Naeim

13 The Changing Role of the Pathologist in the Management of the Cancer Patient
Raymond B. Nagle

14 General Considerations in the Use and Application of Laboratory Tests for the Evaluation of Cancer
Robert M. Nakamura and Wayne W. Grody

15 Autoantibodies, Autoimmunity, and Cancers: Markers for Identification of Early Stages of Tumors
Robert M. Nakamura and Eng M. Tan

16 Molecular Techniques in Cancer Diagnosis and Management
Jeffrey S. Ross, Karen Gray, Rebecca Mosher, and James Stec

17 DNA Repair Defects in Cancer
Ramune Reliene and Robert H. Schiestl

18 Genetic Counseling for Hereditary Cancer Predisposition Testing
Joyce L. Seldon and Patricia A. Ganz

19 Types of Circulating Tumor Markers and Their Clinical Applications
James T. Wu

20 Identification of Risk Factors for Early Neoplasm
James T. Wu

21 Emerging Circulating Tumor Markers
James T. Wu

22 Recent Advances in Molecular Classification and Prognosis of Colorectal Cancer
Tsung-Teh Wu and Asif Rashid
th With the 25 Symposium, we continued the tradition of providing an informal, congenial atmosphere that our participants found conducive to discussing technical program topics. This year's topics included: Session lA Feedstock Supply, Logistics, Processing, and Composition Session IB Enzyme Catalysis and Engineering Session 2 Microbial Catalysis and Engineering Session 3 Bioprocessing including Separations Session 4 Biotechnology for Fuels and Chemicals-Past, Present, and Future Session 5 Biobased Industrial Chemicals Session 6A Biomass Pretreatment and Hydrolysis Session 6B Plant Biotechnology and Feedstock Genomics Special Topics A Microbial Pentose Metabolism Special Topics B International Bioenergy Agency Bioethanol Meeting A summary of these sessions is included at the beginning of each section of the Proceedings. The technical core of the Symposium remains the creation, manipulation, and practical use of new biocatalysts to pro­ duce useful fuels and chemicals. This was shown in both fundamental science discoveries as well as progress reports from commercialization efforts. However, we have continued to expand interest into the bio­ feedstock (plant genomics, production, and pretreatment). While the pro­ duction of sugars from biomass and their subsequent bioconversion into chemicals remains the dominant thrust, areas such as gasification and direct production in plants were presented. The use of molecular biology and genomics to provide new biocatalysts as well as understanding the fundamentals of the microbes, enzymes, and biomass has increased the likely achievement of both near and long-term commercialization goals. This year Dr. J.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.

Google Plus
Powered by Inooga